Clinical Trial Update: Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating venetoclax with BEAM conditioning before autologous stem cell transplant in Non-Hodgkin lymphoma; currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Carmustine (BCNU) (carmustine)
• Etoposide (Etoposide)
• Melphalan (Melphalan)
• Venetoclax (venetoclax)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Non-hodgkin Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING